NYSE: HLIHoulihan Lokey Inc Stock
$150.20-3.08 (-2.01%)
Updated Apr 21, 2025
HLI Price
$150.20
Fair Value Price
N/A
Market Cap
$10.54B
52 Week Low
$123.53
52 Week High
$192.10
P/E
27.31x
P/B
5.06x
P/S
5.1x
PEG
1.51x
Dividend Yield
1.14%
Revenue
$2.24B
Earnings
$358.87M
Gross Margin
100%
Operating Margin
22.25%
Profit Margin
16%
Debt to Equity
0.67
Operating Cash Flow
$716M
Beta
0.9
Next Earnings
May 6, 2025
Ex-Dividend
N/A
Next Dividend
N/A
HLI Overview
Houlihan Lokey, Inc. is an investment bank and financial services company. Its clients include large public and closely held companies, as well as institutions and governments. Offerings include mergers and acquisitions, capital markets, restructuring, distressed M&A, fairness opinions, and valuations. Houlihan Lokey was founded in 1972 and is headquartered in Los Angeles, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine HLI's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Capital Market
Industry Rating
D
HLI
Ranked#15 of 53
Ranked#15 of 53
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $8.26 | A | |
| $37.16 | B | |
| $5.45 | B |
Be the first to know about important HLI news, forecast changes, insider trades & much more!
HLI News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HLI scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HLI ($150.20) is trading above its intrinsic value of $64.43, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
HLI is poor value based on its earnings relative to its share price (27.31x), compared to the US market average (27.14x)
P/E vs Market Valuation
HLI is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more HLI due diligence checks available for Premium users.
Valuation
HLI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
27.31x
Industry
18.41x
Market
27.14x
HLI is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
HLI is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
HLI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.06x
Industry
1.92x
HLI is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
HLI price to earnings growth (PEG)
For valuing profitable companies with growth potential
HLI is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
HLI's financial health
Profit margin
Revenue
$634.4M
Net Income
$95.3M
Profit Margin
15%
HLI's Earnings (EBIT) of $499.12M... subscribe to Premium to read more.
Interest Coverage Financials
HLI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$3.5B
Liabilities
$1.4B
Debt to equity
0.67
HLI's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
HLI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$265.5M
Investing
-$87.4M
Financing
-$37.4M
HLI's operating cash flow ($715.54M)... subscribe to Premium to read more.
Debt Coverage Financials
HLI vs Capital Market Stocks
Houlihan Lokey Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.